MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
OBIO Orchestra BioMed
- 4.920
- +0.120+2.50%
Close Dec 20 16:00 ET
- 4.920
- 0.0000.00%
Post 16:07 ET
187.03MMarket Cap-3.24P/E (TTM)
4.980High4.490Low191.27KVolume4.640Open4.800Pre Close915.85KTurnover1.06%Turnover RatioLossP/E (Static)38.01MShares10.15052wk High4.05P/B89.11MFloat Cap4.22052wk Low--Dividend TTM18.11MShs Float23.390Historical High--Div YieldTTM10.21%Amplitude4.220Historical Low4.788Avg Price1Lot Size
Orchestra BioMed News
Orchestra BioMed Presents Insights on BACKBEAT Study and AVIM Therapy at 2024 ICI Meeting in Tel Aviv
Express News | Orchestra Biomed Announces Avim Therapy Program Presentations at Ici Meeting
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
H.C. Wainwright Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $14
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully
Chardan Capital Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $20
Orchestra BioMed Holdings: Strategic Financial Developments and Clinical Progress Justify Buy Rating
Orchestra BioMed Reports Q EPS (41c), Consensus (43c)
Orchestra BioMed Holdings 3Q Loss/Shr 41c >OBIO
Orchestra BioMed | 10-Q: Q3 2024 Earnings Report
Earnings Flash (OBIO) ORCHESTRA BIOMED Posts Q3 Revenue $987,000
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
Express News | Orchestra Biomed Q3 EPS USD -0.41 Vs. IBES Estimate USD -0.43
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
Orchestra BioMed Executive Acquires Shares Worth Over $47k
Orchestra BioMed Hldgs Analyst Ratings
H.C. Wainwright Initiates Orchestra BioMed(OBIO.US) With Buy Rating, Announces Target Price $14
Express News | Orchestra Biomed Holdings, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $14
Orchestra BioMed Reports Q2 Results
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.